Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children before and after artemisinin-based combination treatments.

Authors:
Address: Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria. akinsowunmi@hotmail.com
Journal:

Publication:

abstract

BACKGROUND:

artemisinin-based combination treatments (ACTs) are the recommended first-line antimalarials globally, but their influence on the Risk factors associated with gametocyte carriage has had little evaluation in endemic areas.

METHODS:

The risk factors associated with gametocytaemia at presentation and after ACTs were evaluated in 835 children assigned to artesunate, artesunate-amodiaquine, artesunate-mefloquine or artemether-lumefantrine.

RESULTS:

Gametocyte carriage at enrolment was 8.4%. During follow-up, 24 patients (2.8%) developed gametocytaemia, which in 83% (20 patients) had developed by day 7 following treatment. In a multiple regression model, 2 factors were independent risk factors for the presence of gametocytaemia at enrolment, namely age <3 years (adjusted odds ratio 2.03, 95% confidence interval 1.01-4.05; p = 0.04) and enrolment before 2009 (adjusted odds ratio 4.2, 95% confidence interval 2.09-8.44; p < 0.001). Haematocrit <25% and parasitaemia <50,000/μl blood were associated with an increased risk of gametocytaemia. Following treatment, 3 factors were independent risk factors for gametocytaemia, namely gametocytaemia at enrolment (adjusted odds ratio 46.39, 95% confidence interval 22.3-96.46; p < 0.0001) and treatment with artesunate (adjusted odds ratio 6.74, 95% confidence interval 1.79-25.27; p = 0.005) or artesunate-mefloquine (adjusted odds ratio 9.66, 95% confidence interval 2.87-32.46; p < 0.0.0001) relative to other ACTs.

CONCLUSION:

ACTs modified the risk factors associated with gametocyte carriage after use.

Related Articles
Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
Lancet Infect Dis. 2010
Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo AP, Naing AL, Nyo MY, Myint NZ, Imwong M, et al. Lancet Infect Dis. 2010 Oct; 10(10):673-81. Epub 2010 Sep 9.
Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children.
Parasitology. 2004
Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children.
Sowunmi A, Fateye BA, Adedeji AA, Fehintola FA, Happi TC. Parasitology. 2004 Sep; 129(Pt 3):255-62.
Plasmodium falciparum gametocyte sex ratios in symptomatic children treated with antimalarial drugs.
Acta Trop. 2009
Plasmodium falciparum gametocyte sex ratios in symptomatic children treated with antimalarial drugs.
Sowunmi A, Balogun ST, Gbotosho GO, Happi CT. Acta Trop. 2009 Feb; 109(2):108-17. Epub 2008 Nov 5.
Review Artemisinin-based combination therapy for treating uncomplicated malaria.
Cochrane Database Syst Rev. 2009
Review Artemisinin-based combination therapy for treating uncomplicated malaria.
Sinclair D, Zani B, Donegan S, Olliaro P, Garner P. Cochrane Database Syst Rev. 2009 Jul 8; (3):CD007483. Epub 2009 Jul 8.
Review [Combined antimalarial therapy using artemisinin].
Parassitologia. 2004
Review [Combined antimalarial therapy using artemisinin].
Majori G. Parassitologia. 2004 Jun; 46(1-2):85-7.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.